Gubra CEO after first outlook upgrade: "The business is just doing far better than we could have imagined"
Gubra’s CEO, Henrik Blou, acknowledges that the company may be playing its cards conservatively, though he emphasizes that the wild growth was impossible to predict earlier this year.
When Gubra announces a dramatic upward adjustment of expectations just six months after its IPO in March, it is in a way a sign that the contract research organization (CRO) and biotech company is playing its newly dealt cards on the stock market relatively cautiously.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
